14-094
Showing 1 - 25 of 6,792
GSK's Phase IIb Malaria Vaccine Trial Entitled "Efficacy, Safety
Active, not recruiting
- Malaria
-
Kumasi, Ghana
- +1 more
Jun 23, 2022
Hunter Syndrome Trial in Worldwide (Idursulfase-IT, Elaprase)
Active, not recruiting
- Hunter Syndrome
-
Oakland, California
- +8 more
Aug 31, 2022
Infertility Trial in Guangzhou (GenSci094, Placebo RecFSH / follitropin alfa, Biological: RecFSH / Follitropin alfa (Days 1 to
Recruiting
- Infertility
- GenSci094
- +7 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital, Sun Yat-sen University Guangdong
Oct 17, 2023
Cytomegalovirus (CMV) Infection Trial in Worldwide (Letermovir oral granules, Letermovir tablet, Letermovir intravenous)
Active, not recruiting
- Cytomegalovirus (CMV) Infection
- Letermovir oral granules
- +2 more
-
Duarte, California
- +39 more
Jan 9, 2023
Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Group A
-
Peshawar, KPK, PakistanHayatabad Medical Complex
Apr 3, 2022
Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)
Recruiting
- Metastatic Uveal Melanoma
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022
Esophagogastric Adenocarcinoma Trial in United States (Nintedanib)
Completed
- Esophagogastric Adenocarcinoma
-
Basking Ridge, New Jersey
- +5 more
Dec 30, 2020
Healthy, Nutritional and Metabolic Diseases Trial in México (Dietary Supplement: A package containing a mix of functional foods)
Not yet recruiting
- Healthy
- Nutritional and Metabolic Diseases
- Dietary Supplement: A package containing a mix of functional foods
-
México, Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Feb 1, 2023
Epilepsy, Seizures Trial in Charleston (Epitel's™ Remote EEG Monitoring System's (REMI™))
Not yet recruiting
- Epilepsy
- Seizures
- Epitel's™ Remote EEG Monitoring System's (REMI™)
-
Charleston, South CarolinaMedical University of South Carolina
Aug 31, 2023
Spastic Paraplegia Type 50 Trial in Toronto (MELPIDA)
Active, not recruiting
- Spastic Paraplegia Type 50
- MELPIDA
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Oct 5, 2023
Post Traumatic Stress Disorder, HIV Trial in Bronx (Trauma-focused psychodynamic psychotherapy)
Not yet recruiting
- Post Traumatic Stress Disorder
- HIV
- Trauma-focused psychodynamic psychotherapy
-
Bronx, New YorkAlbert Einstein College of Medicine
Jun 30, 2023
NSCLC Trial in Guangzhou (PLB1001)
Active, not recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 15, 2023
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Insufficiency;Cardiac Trial in Guadalajara (L-alanyl-L-glutamine dipeptide, Placebo)
Completed
- Insufficiency;Cardiac
- L-alanyl-L-glutamine dipeptide
- Placebo
-
Guadalajara, Jalisco, MexicoInstituto Mexicano del Seguro Social
Sep 29, 2023
Postpartum Depression Trial in United States (Placebo, SAGE-547 90 µg/kg/h)
Completed
- Postpartum Depression
- Placebo
- SAGE-547 90 μg/kg/h
-
Chandler, Arizona
- +31 more
Jan 20, 2022
Oral Cavity Squamous Cell Carcinoma Trial in Mumbai (Sentinel node biopsy)
Recruiting
- Oral Cavity Squamous Cell Carcinoma
- Sentinel node biopsy
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Jul 15, 2023
Neurofibromatosis 1, Plexiform Neurofibroma (PN) Trial in Worldwide (Selumetinib, Placebo)
Recruiting
- Neurofibromatosis 1
- Plexiform Neurofibroma (PN)
- Selumetinib
- Placebo
-
Gainesville, Florida
- +40 more
Jan 16, 2023
Pulmonary Disease, Chronic Obstructive Trial in Canada, Denmark (GSK2269557, Placebo, DISKUS)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK2269557
- +3 more
-
Vancouver, British Columbia, Canada
- +5 more
Aug 12, 2021
Gastroenteritis Trial in Japan (Placebo, HIL-214)
Recruiting
- Gastroenteritis
- Placebo
- HIL-214
-
Fukui-Shi, Japan
- +3 more
Aug 18, 2023
CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS
Completed
- Atopic Dermatitis
- Cosmetic study
-
Rio de Janeiro, BrazilCIDP
Mar 13, 2023
Central Diabetes Insipidus (cDI) Trial in Basel (Intranasal OXT, Placebo nasal spray)
Not yet recruiting
- Central Diabetes Insipidus (cDI)
- Intranasal OXT
- Placebo nasal spray
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Endocrinology, Diabetes
Sep 6, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Xevinapant, Placebo)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Xevinapant
- Placebo
- (no location specified)
Feb 10, 2023
Toxicity;Chemical Trial (HOPO 14-1)
Not yet recruiting
- Toxicity;Chemical
- HOPO 14-1
- (no location specified)
Nov 17, 2022
Increase Repeat Blood Donation Attempts Among First-time Donors Trial (WhatsApp, docudrama)
Not yet recruiting
- Increase Repeat Blood Donation Attempts Among First-time Donors
- docudrama
- (no location specified)
Jul 25, 2023